"bharat-biotech-bb"

Ocugen said Bharat Biotech completed and posted its phase 3 clinical trial results for Covaxin demonstrating 77.8 per cent efficacy against overall Covid-19 disease

Says supply of nearly 70 million doses of its Covid-19 vaccine to date proves its safety standards

Several research activities are being carried out to study Variants of Concern and assess their suitability for follow-up booster doses, the company said here on Tuesday.

Joel Reifman, Consul General, US Consulate General, Hyderabad said Telangana too has played a very significant role in the Indian healthcare sector by giving the nation the first indigenously developed vaccine by Bharat Biotech.

Bharat Biotech's 'pre-submission' meeting with the World Health Organization (WHO) will take on Wednesday for the approval for Covaxin.

Innovators with specialised expertise in product development, and large-scale manufacturing, should be allowed to maintain a differential pricing strategy for governments and private hospitals, says the Covaxin maker

Bharat Biotech's Joint Managing Director Suchitra Ella's tweet draws bouquets and brickbats.

"In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28," it said.

The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.

Around 3.5 crore individuals will have to be administered the vaccine in the State